Rate My Professor Glenn Reeves

Conjoint Associate Professor Glenn Reeves holds a position in the School of Medicine and Public Health (Immunology and Microbiology) at the University of Newcastle, within the College of Health, Medicine and Wellbeing. He graduated with an MBBS from the University of Sydney in 1986, obtained fellowship of the Royal Australasian College of Physicians (FRACP) in 1998 and the Royal College of Pathologists of Australasia (FRCPA) in 1999, and completed a Master of Medical Statistics in 2006. Reeves completed his physician training at Royal Newcastle Hospital, Hunter Area Health Service, and John Hunter Hospital. He has authored more than 56 academic publications and secured 26 research grants and projects throughout his career.

Reeves' research focuses on immunology, autoimmunity, and immunopathology, with special interests in autoimmune conditions including coeliac disease, systemic lupus erythematosus, scleroderma, and pulmonary arterial hypertension. Key publications include 'Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing "the Epidemic" of Chronic Diseases' (2018), 'Impact of Hydroxychloroquine Therapy on Chronic Urticaria: Chronic Autoimmune Urticaria Study and Evaluation' (2004), and 'Diagnostic Accuracy of Coeliac Serological Tests: A Prospective Study' (2006). As a practising immunologist, he treats allergy, autoimmunity, and immunodeficiency, serving as Director of the Coastal Immunology and Allergy Clinic and the Autoimmune Resource and Research Centre, and Senior Staff Specialist in Immunology, Immunopathology, and Infectious Diseases at John Hunter and Newcastle Hospitals. Reeves is chief investigator on multicentre trials such as the Multicentre Research Trial of Optimal Approaches to Diagnosing and Monitoring Coeliac Disease, advises on therapies including sotatercept for pulmonary arterial hypertension, anifrolumab for SLE, and avacopan for ANCA-vasculitis, teaches medical students and trainees, and provides expert witness testimony in anaphylaxis-related cases.